SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > September 2014

« Previous month Next month »
update

Consort Medical cites growing Bespak as driver for £230m Aesica acquisition

30-Sep-2014 - Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Impax settles lawsuit related to manufacturing issues for $8m

30-Sep-2014 - Hampered by manufacturing issues, Impax Laboratories has decided to settle a lawsuit over allegations related to the issues in order “to eliminate the uncertainty, distraction, burden and expense of further...

Vorsprung durch TechnoPharm: Pharma tech firms head to Nuremberg

29-Sep-2014 - in-Pharmatechnologist.com is live from Nuremberg to bring you the best from TechnoPharm and POWTECH 2014, Europe's largest processing and powder shows.

FDA says no to anti-addiction rule on Ritalin, painkillers

29-Sep-2014 - The US Food and Drug Administration has rejected a petition to force drugmakers to reformulate CNS-acting drugs like Adderall, Ritalin, and painkillers to prevent illegal use, but experts say the...

India accuses American Enterprise Institute researchers of "smear campaign"

29-Sep-2014 - The Indian Government has accused the authors of a paper analysing the quality of drugs sold in Africa of leading an attack on the Indian drug industry, but researcher Roger...

People on the Move

GSK appoints RBS chairman, AstraZeneca knight joins R&D charity

29-Sep-2014 - The Chairman who steered the Royal Bank of Scotland Group (RBS) after its financial crisis losses will join GSK’s Board as a Non-Executive Director and...

'Worst addiction epidemic in US history' sparks call for Hamburg's resignation

25-Sep-2014 - An anti-addiction group has called for a change in leadership at the US FDA following the approval of Zohydro and other high-dose opioid analgesics.

Acorda gains pulmonary drug delivery tech in $525 Civitas deal

25-Sep-2014 - Acorda has gained a pulmonary delivery technology and a GMP manufacturing site in Massachusetts along with a Parkinson’s disease candidate in its $525m (€410m) acquisition of Civitas.

Partnership looks to expand UK drug manufacturing

25-Sep-2014 - The Medicines Manufacturing Industry Partnership (MMIP) between the ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association) and a number of companies aims to make the UK a more...

CORRECTION

Boehringer cutting German workforce by 600 but production jobs safe for now

24-Sep-2014 - Hundreds of workers brought in to help fix manufacturing issues at a Boehringer Ingelheim facility will not be affected despite the firm looking to shave 600 jobs in a €450m...

WHO welcomes industry response to Ebola crisis but calls for new drugs

24-Sep-2014 - The Pharma industry has responded to the Ebola crisis in West Africa with developmental vaccines and aid donations, but drugmakers still need to be incentivised to develop new therapies according...

Generic Sovaldi makers could pocket upwards of $600m says analyst

24-Sep-2014 - The market opportunity for each Indian drugmakers granted a license to manufacture Gilead’s hepatitis C drug Sovaldi could be worth over $600m, an analyst has calculated.

GS1 offers guide for adhering to new US supply chain security law

24-Sep-2014 - As the US Drug Supply Chain Security Act (DSCSA) traceability requirements become mandatory in 2015, standards group GS1 is offering a 137-page guideline to help manufacturers follow the new stipulations.

Production on hold at GSK vaccine plant after poliovirus enters water supply

23-Sep-2014 - GlaxoSmithKline will not restart production at a vaccine plant in Belgium until an independent investigation determines how liquid contaminated with polio virus was released into the local sewage system.

Pharmacies banned from compounding for docs without prescription

23-Sep-2014 - The US Food and Drug Administration (FDA) says compounding pharmacies must not manufacture medicines for hospitals and doctors’ offices, except for named patients.

News in brief

Hikma: API facility bolsters our oncology pipeline

23-Sep-2014 - Hikma has opened a new API facility in Jordan to support its oncology pipeline.

Novartis cuts 83 more jobs at closing NY Diovan plant

23-Sep-2014 - Novartis has announced a second round of lay-offs at its manufacturing site in Suffern, New York ahead of the plant’s closure in 2016.

Say ‘cheese’: database collects pill photos

22-Sep-2014 - The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database for use in apps to improve public safety.

Telormedix granted 'most important patent ' for TLR agonist bladder cancer drug

22-Sep-2014 - Telormedix has been granted a European patent for increasing the solubility of its lead bladder cancer toll-like receptors (TLR) treatment Vesimune.

Pfizer and Irish port authorities working to stop API plant gathering dust

22-Sep-2014 - Pfizer is working with Irish authorities to avoid a repeat of a 2013 incident when dust produced from Cork harbour entered its nearby API facility.

Breaking news

Merck KGaA: $17bn 'Rolls Royce' Sigma-Aldrich to keep major St Louis site

22-Sep-2014 - The $17bn (€13.2bn) acquisition of Sigma-Aldrich is “not just a milestone but a quantum leap” for Merck KGaA, the firm says.

Diluent mix-up not vaccine most probable cause of Syrian deaths says WHO

18-Sep-2014 - Use of the muscle relaxant atracuriam to resuspend freeze-dried measles vaccines instead of the proper diluent almost certainly caused the death of more than a dozen Syrian infants according to...

Scientists discover novel antibiotic in vagina

18-Sep-2014 - Scientists looking to solve the looming threat of antimicrobial resistance have discovered an antibiotic in the vagina.

Dispatches from ChemOutsourcing

ICH elemental impurities guideline expected to be finalized at end of September

18-Sep-2014 - After much discussion and some confusion , the ICH’s (International Conference on Harmonization) Q3D guideline , which will govern elemental impurities in final drug products, is expected to be finalized at the...

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...